Structure Therapeutics Inc (NAS:GPCR)
$ 49.4 -0.57 (-1.14%) Market Cap: 3.52 Bil Enterprise Value: 2.19 Bil PE Ratio: 0 PB Ratio: 2.60 GF Score: 30/100

Structure Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 02:00PM GMT
Release Date Price: $41.25 (+9.21%)
Unidentified Participant

Awesome. Well, good morning, everyone. Thanks for joining us here at the Goldman Sachs Healthcare Conference. Thrilled to be joined on stage today by the team from Structure Therapeutics. And it's been a really busy week with respect to obesity, so I would love to actually open up there.

Questions & Answers

Unidentified Participant

We're coming on the back of ADA. What did you learn over the weekend. And how does that kind of inform your view of the obesity landscape as it stands today?

Raymond Stevens
Structure Therapeutics Inc - Chief Executive Officer, Director

So one, we had a great ADA just coming from New Orleans.

Dr. Julio Rosenstock gave the opening lecture with our data, our access data.

And I think what we sort of took home from that, we also had a Nature Medicines publication that came out simultaneously to the presentation on Friday of ADA.

We clearly, coming out of the ADA, we clearly have the best-in-class profile. We just saw data from AstraZeneca come out

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot